Antimicrobial Stewardship Goes Mainstream In July 2016, the Food and Drug Administration (FDA) issued a safety alert on the serious side effects associated with quinolones, a class of antibiotics that includes ciprofloxacin and levofloxacin. These drugs are convenient in many ways, notably because they treat a broad range of infections and are effective both intravenously […]
Discover best-in-market prices on clinically preferred products―together with a suite of applications supporting pharmacy operations and analytics, and innovative strategies to address industry initiatives and issues.
“The demand for trained pharmacy professionals has increased in past years,” according to the American Association of Colleges of Pharmacy (AACP), “due to the rapid growth of the healthcare and pharmaceutical industries, and the growing elderly population. The number of pharmacists in healthcare services is also growing, as pharmacists become more actively involved in drug […]
LAS VEGAS, Nevada—July 18, 2017—HealthTrust has recognized 21 individuals with its highest honor during the 2017 HealthTrust University Conference in Las Vegas. The healthcare performance improvement company established its annual Member Recognition Award program to acknowledge outstanding contributions of member organizations for demonstrating best practices and achieving operational excellence benefitting providers and their patients. Awards […]
The 340B Drug Pricing Program requires drug manufacturers participating in Medicaid to provide outpatient drugs at significantly reduced prices to eligible healthcare organizations or covered entities, such as safety-net hospitals. This program was originally set up in 1992 to provide support to safety-net hospitals that take care of a large number of the poor and […]
Rheumatoid arthritis (RA) is the latest high-profile disease for which the Institute for Clinical and Economic Review (ICER) has constructed a “value framework” for assessing and comparing available drug treatments. In April, ICER issued a comprehensive, 529-page report on targeted immune modulators (TIMs) for RA that covers 14 medicines—all but two biologics, and none biosimilars. […]
In 2014, California became the first state to require acute care hospitals to implement antimicrobial stewardship programs in their facilities. Nearly three years later, it remains the only state in the nation with such a law—but that is set to change. In June 2016, the Centers for Medicare & Medicaid Services (CMS) announced proposed changes […]
In 2014, HealthTrust established the nation’s first corporate-based training program for future pharmacy leaders that provides early career exposure to critical business functions, value-based purchasing and the economic realities of modern medicine, including better management of limited healthcare resources.